CN105769381B - A kind of biological sticking patch for tissue damage reparation - Google Patents
A kind of biological sticking patch for tissue damage reparation Download PDFInfo
- Publication number
- CN105769381B CN105769381B CN201510273678.1A CN201510273678A CN105769381B CN 105769381 B CN105769381 B CN 105769381B CN 201510273678 A CN201510273678 A CN 201510273678A CN 105769381 B CN105769381 B CN 105769381B
- Authority
- CN
- China
- Prior art keywords
- cell
- sticking patch
- biomaterial
- base layer
- basalis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000000451 tissue damage Effects 0.000 title claims abstract description 7
- 231100000827 tissue damage Toxicity 0.000 title claims abstract description 7
- 239000012620 biological material Substances 0.000 claims abstract description 20
- 239000011159 matrix material Substances 0.000 claims abstract description 20
- 230000012010 growth Effects 0.000 claims abstract description 5
- 210000004027 cell Anatomy 0.000 claims description 57
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 10
- 235000013870 dimethyl polysiloxane Nutrition 0.000 claims description 10
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 10
- 210000000130 stem cell Anatomy 0.000 claims description 10
- CXQXSVUQTKDNFP-UHFFFAOYSA-N octamethyltrisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 claims description 8
- 238000004987 plasma desorption mass spectroscopy Methods 0.000 claims description 8
- 210000004116 schwann cell Anatomy 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 7
- 102000008186 Collagen Human genes 0.000 claims description 2
- 108010035532 Collagen Proteins 0.000 claims description 2
- 108010022355 Fibroins Proteins 0.000 claims description 2
- 229920000954 Polyglycolide Polymers 0.000 claims description 2
- 229920001436 collagen Polymers 0.000 claims description 2
- 210000004263 induced pluripotent stem cell Anatomy 0.000 claims description 2
- 210000002901 mesenchymal stem cell Anatomy 0.000 claims description 2
- 229920000747 poly(lactic acid) Polymers 0.000 claims description 2
- 239000004633 polyglycolic acid Substances 0.000 claims description 2
- 239000004626 polylactic acid Substances 0.000 claims description 2
- 230000001413 cellular effect Effects 0.000 claims 4
- 239000008280 blood Substances 0.000 claims 1
- 210000004369 blood Anatomy 0.000 claims 1
- 239000000835 fiber Substances 0.000 claims 1
- 238000007493 shaping process Methods 0.000 claims 1
- 239000011148 porous material Substances 0.000 abstract description 8
- 238000009826 distribution Methods 0.000 abstract description 7
- 230000017423 tissue regeneration Effects 0.000 abstract description 4
- 230000009286 beneficial effect Effects 0.000 abstract description 2
- 230000035699 permeability Effects 0.000 abstract description 2
- 238000011069 regeneration method Methods 0.000 abstract description 2
- 230000008467 tissue growth Effects 0.000 abstract description 2
- 229920001661 Chitosan Polymers 0.000 description 23
- 239000002609 medium Substances 0.000 description 17
- 238000002360 preparation method Methods 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 238000010586 diagram Methods 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 210000001185 bone marrow Anatomy 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 210000001519 tissue Anatomy 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 230000004069 differentiation Effects 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 4
- 241000700159 Rattus Species 0.000 description 4
- 239000003431 cross linking reagent Substances 0.000 description 4
- 102000029816 Collagenase Human genes 0.000 description 3
- 108060005980 Collagenase Proteins 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 3
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 3
- 229960002424 collagenase Drugs 0.000 description 3
- 210000002744 extracellular matrix Anatomy 0.000 description 3
- 239000012091 fetal bovine serum Substances 0.000 description 3
- 210000002950 fibroblast Anatomy 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- UZOVYGYOLBIAJR-UHFFFAOYSA-N 4-isocyanato-4'-methyldiphenylmethane Chemical compound C1=CC(C)=CC=C1CC1=CC=C(N=C=O)C=C1 UZOVYGYOLBIAJR-UHFFFAOYSA-N 0.000 description 2
- 239000012583 B-27 Supplement Substances 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- OHCQJHSOBUTRHG-KGGHGJDLSA-N FORSKOLIN Chemical compound O=C([C@@]12O)C[C@](C)(C=C)O[C@]1(C)[C@@H](OC(=O)C)[C@@H](O)[C@@H]1[C@]2(C)[C@@H](O)CCC1(C)C OHCQJHSOBUTRHG-KGGHGJDLSA-N 0.000 description 2
- 102000003974 Fibroblast growth factor 2 Human genes 0.000 description 2
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 description 2
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 2
- 102000004142 Trypsin Human genes 0.000 description 2
- 108090000631 Trypsin Proteins 0.000 description 2
- 239000012670 alkaline solution Substances 0.000 description 2
- 230000000735 allogeneic effect Effects 0.000 description 2
- APKFDSVGJQXUKY-INPOYWNPSA-N amphotericin B Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-INPOYWNPSA-N 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 210000002919 epithelial cell Anatomy 0.000 description 2
- 210000003195 fascia Anatomy 0.000 description 2
- 239000004088 foaming agent Substances 0.000 description 2
- UQEAIHBTYFGYIE-UHFFFAOYSA-N hexamethyldisiloxane Polymers C[Si](C)(C)O[Si](C)(C)C UQEAIHBTYFGYIE-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 206010033675 panniculitis Diseases 0.000 description 2
- -1 polydimethylsiloxane Polymers 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- 239000010703 silicon Substances 0.000 description 2
- 210000004003 subcutaneous fat Anatomy 0.000 description 2
- 210000004304 subcutaneous tissue Anatomy 0.000 description 2
- 239000012588 trypsin Substances 0.000 description 2
- 238000001291 vacuum drying Methods 0.000 description 2
- 206010000372 Accident at work Diseases 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- UHDGCWIWMRVCDJ-CCXZUQQUSA-N Cytarabine Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O1 UHDGCWIWMRVCDJ-CCXZUQQUSA-N 0.000 description 1
- SUZLHDUTVMZSEV-UHFFFAOYSA-N Deoxycoleonol Natural products C12C(=O)CC(C)(C=C)OC2(C)C(OC(=O)C)C(O)C2C1(C)C(O)CCC2(C)C SUZLHDUTVMZSEV-UHFFFAOYSA-N 0.000 description 1
- 102000016911 Deoxyribonucleases Human genes 0.000 description 1
- 108010053770 Deoxyribonucleases Proteins 0.000 description 1
- 241000283073 Equus caballus Species 0.000 description 1
- 239000012580 N-2 Supplement Substances 0.000 description 1
- 206010039203 Road traffic accident Diseases 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 210000001691 amnion Anatomy 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- OHCQJHSOBUTRHG-UHFFFAOYSA-N colforsin Natural products OC12C(=O)CC(C)(C=C)OC1(C)C(OC(=O)C)C(O)C1C2(C)C(O)CCC1(C)C OHCQJHSOBUTRHG-UHFFFAOYSA-N 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229960000684 cytarabine Drugs 0.000 description 1
- 210000001951 dura mater Anatomy 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 210000004700 fetal blood Anatomy 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000002055 immunohistochemical effect Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 230000005486 microgravity Effects 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 210000000578 peripheral nerve Anatomy 0.000 description 1
- 210000004303 peritoneum Anatomy 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 210000003497 sciatic nerve Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 210000004876 tela submucosa Anatomy 0.000 description 1
- 210000002303 tibia Anatomy 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Materials For Medical Uses (AREA)
Abstract
本发明公开了一种用于组织损伤修复的生物补片,包括生物材料基底层和细胞基质层,基质层附着在基底层上,基底层与细胞基质层的接触面上设有若干个平行的沟槽。本发明生物补片基底层同时具有多孔和沟槽纹路结构,不但可以调控细胞的取向性生长和分布,沟槽纹路结构所具有的力学性能可以使细胞基质层能够更好的粘附在基底层上,避免脱落。本发明所述产品具有稳定的结构,合适的孔径、孔隙率及通透性,能够模拟正常组织结构,能够提供组织生长的管道及细胞基质,并且可以承载利于组织修复和再生的细胞。
The invention discloses a biological patch for repairing tissue damage, which comprises a biological material base layer and a cell matrix layer, the base layer is attached to the base layer, and several parallel patches are arranged on the contact surface between the base layer and the cell matrix layer. groove. The base layer of the biological patch of the present invention has both porous and groove texture structures, which can not only regulate the oriented growth and distribution of cells, but also the mechanical properties of the groove texture structure can enable the cell matrix layer to better adhere to the base layer on, to avoid falling off. The product of the present invention has a stable structure, suitable pore size, porosity and permeability, can simulate normal tissue structure, can provide tissue growth channels and cell matrix, and can carry cells that are beneficial to tissue repair and regeneration.
Description
技术领域technical field
本发明涉及医疗器械领域,特别涉及一种用于组织损伤修复的生物补片。The invention relates to the field of medical devices, in particular to a biological patch for repairing tissue damage.
背景技术Background technique
现实社会中交通事故、工伤事故、运动意外及临床手术等事件均会造成组织损伤,临床上多使用作为生物补片进行替代和修复人体组织的材料。生物补片是指取自同种一种对组织,经脱细胞处理去除组织中含有的各种细胞而完整保留细胞外基质的三维框架结构并能用于修复人体软组织的材料。根据组织来源可分为同种异体材料如真皮脱细胞基质、羊膜、硬脑膜等,异种异体材料如猪小肠黏膜下层、牛、马的心包、牛腹膜等。虽然这种天然生物补片已经商品化,但是制备繁琐,价格高昂。寻找价格低廉、简便易得、生物相容性好的人工合成生物补片来替代天然生物补片仍然是研究的热点。In the real world, traffic accidents, industrial accidents, sports accidents, and clinical operations will cause tissue damage. In clinical practice, materials are often used as biological patches to replace and repair human tissues. Biological patch refers to a material taken from the same kind of tissue, which is decellularized to remove various cells contained in the tissue while retaining the three-dimensional framework structure of the extracellular matrix and can be used to repair human soft tissue. According to the tissue source, it can be divided into allogeneic materials such as dermal acellular matrix, amniotic membrane, dura mater, etc., and heterogeneous materials such as porcine small intestinal submucosa, bovine, equine pericardium, bovine peritoneum, etc. Although this natural biological patch has been commercialized, its preparation is cumbersome and expensive. It is still a research hotspot to look for cheap, easy to obtain, and good biocompatibility synthetic bio-mesh to replace natural bio-mesh.
发明内容:Invention content:
本发明的目的在于提供一种生物相容性好、价格低廉、简便易得的用于组织损伤修复的生物补片。The purpose of the present invention is to provide a biological patch for repairing tissue damage with good biocompatibility, low price and easy availability.
本发明的技术解决方案是:Technical solution of the present invention is:
一种用于组织损伤修复的生物补片,包括生物材料基底层和细胞基质层,基质层附着在基底层上,基底层与细胞基质层的接触面上设有若干个平行的沟槽。沟槽可以为突出于基底层表面的凸形沟槽,也可以为自基底层表面向内凹陷的沟槽形状。沟槽为横向或纵向排布。A biological patch for repairing tissue damage includes a biomaterial base layer and a cell matrix layer, the base layer is attached to the base layer, and several parallel grooves are arranged on the contact surface between the base layer and the cell matrix layer. The groove can be a convex groove protruding from the surface of the base layer, or a groove shape concave inward from the surface of the base layer. Grooves are arranged horizontally or vertically.
优选沟槽的尺寸为:宽为10-50μm,深为10-30μm。Preferably, the size of the trench is 10-50 μm wide and 10-30 μm deep.
上述的生物补片,所述生物材料基底层上的孔隙率为50%-90%,且孔径为10μm-100μm。In the biological patch mentioned above, the porosity on the base layer of the biological material is 50%-90%, and the pore diameter is 10 μm-100 μm.
上述的人工合成生物补片,所述生物材料基底层厚度为0.1-3mm。In the aforementioned synthetic biological patch, the thickness of the base layer of the biological material is 0.1-3mm.
上述的人工合成生物补片,所述生物材料基底层由丝素蛋白、壳聚糖、胶原、聚乳酸或聚羟基乙酸中的一种或几种制成。In the aforementioned synthetic biological patch, the base layer of the biological material is made of one or more of silk fibroin, chitosan, collagen, polylactic acid or polyglycolic acid.
上述的生物补片,所述细胞基质层是自体的或同种异体来源细胞分泌形成后脱细胞而获得,所述细胞是施万细胞、皮肤来源的成纤维细胞、皮肤干细胞、骨髓间充质干细胞、脐血干细胞或诱导多潜能干细胞中的一种或几种。In the above-mentioned biological patch, the cell matrix layer is obtained by decellularization after autologous or allogeneic source cells are secreted and formed, and the cells are Schwann cells, skin-derived fibroblasts, skin stem cells, bone marrow mesenchymal One or more of stem cells, umbilical cord blood stem cells or induced pluripotent stem cells.
上述生物补片不含有发泡剂和/或交联剂。The bio-patch described above does not contain foaming agents and/or cross-linking agents.
本发明还公开了上述生物补片的制备方法,The present invention also discloses a preparation method of the above-mentioned biological patch,
(1)设计PDMS弹性印章纹路,将生物材料溶液加到印章上,成型脱模后采用冻干的方法制备获得表面具有沟槽纹路的生物材料基底层;(1) Design the texture of the PDMS elastic stamp, add the biomaterial solution to the stamp, and use the freeze-drying method to prepare the biomaterial base layer with grooves on the surface after molding and demoulding;
(2)将生物材料基底层与细胞进行培养,得到贴附生长有细胞的生物材料基底层;(2) culturing the base layer of the biomaterial and the cells to obtain the base layer of the biomaterial attached with cells;
(3)将生长有细胞的生物材料基底层进行脱细胞处理,将其进一步进行冻干,得到生物补片。(3) Decellularize the basal layer of the biological material on which the cells grow, and further freeze-dry it to obtain a biological patch.
本发明的一个优选方案如下:A preferred version of the present invention is as follows:
根据微沟槽的尺寸大小对细胞的形状和铺展行为影响的原则,设计可以引导神经细胞的取向分布的具有沟槽状的微图形结构。According to the principle that the size of the micro-groove affects the shape and spreading behavior of cells, a groove-shaped micro-pattern structure that can guide the orientation distribution of nerve cells is designed.
本发明所使用的弹性印章为聚二甲基硅氧烷(polydimethylsiloxane,PDMS),其制备方法为将室温下配制好的PDMS液体和交联剂按10:1的比例混合均匀后,浇铸到事先采用掩膜曝光获得的具有横向或纵向的沟槽状微图形化分布的硅片基母模板上,然后将其放入真空干燥箱中抽真空排除气泡,并进行干燥固化,最后进行固化后剥离即得到平面PDMS弹性印章。The elastic stamp used in the present invention is polydimethylsiloxane (polydimethylsiloxane, PDMS), and its preparation method is to mix the PDMS liquid prepared at room temperature and the cross-linking agent in a ratio of 10:1, and then cast it to the On the silicon wafer-based master template with horizontal or vertical groove-like micro-patterned distribution obtained by mask exposure, then put it in a vacuum drying oven to vacuumize to remove air bubbles, dry and cure, and finally peel off after curing That is, a planar PDMS elastic stamp is obtained.
用乙酸溶解壳聚糖配制一定浓度(1%、2%和5%)的溶液,然后将该溶液滴加在PDMS上,置于-60℃--90℃,冷冻2-4小时,将冷冻后壳聚糖冰体置于碱性溶液中和固定,用水清洗;对定型的壳聚糖基底层进行冷冻干燥,得到具有多孔结构、表面具有沟槽状分布的多孔壳聚糖基底层。Dissolve chitosan with acetic acid to prepare a solution with a certain concentration (1%, 2% and 5%), then add the solution dropwise on PDMS, place at -60°C--90°C, freeze for 2-4 hours, and freeze After that, the chitosan ice body is placed in an alkaline solution, fixed, and washed with water; the shaped chitosan base layer is freeze-dried to obtain a porous chitosan base layer with a porous structure and groove-like distribution on the surface.
将多孔壳聚糖基底层进行三维细胞培养得到表面贴附生长有细胞的壳聚糖基底层取出。将生长有细胞的壳聚糖基底层进行脱细胞处理,将其进一步进行冻干,得到本发明所述生物补片。The porous chitosan base layer is subjected to three-dimensional cell culture to obtain the chitosan base layer with cells attached to the surface and taken out. Decellularize the chitosan base layer with cells, and further lyophilize it to obtain the biological patch of the present invention.
使用扫描电镜检测本发明所述生物补片孔隙的孔径为10μm-100μm。本发明生物补片基底层同时具有多孔和沟槽纹路结构,不但可以调控细胞的取向性生长和分布,沟槽纹路结构所具有的力学性能可以使细胞基质层能够更好的粘附在基底层上,避免脱落。本发明所述产品具有稳定的结构,合适的孔径、孔隙率及通透性,能够模拟正常组织结构,能够提供组织生长的管道及细胞基质,并且可以承载利于组织修复和再生的细胞,本发明的产品所用材料为天然可降解性材料,与人体有着良好的生物相容性,制得的产品不含有由制备工艺带入的外源性毒、副作用的发泡剂和交联剂。本发明具有很好的抗拉强度且具有细胞基质层,更有利于输送细胞生长过程所需的营养物质,给细胞提供良好的生长环境。使用效果好。本发明方法简便易行。The pore diameter of the pores of the biological patch of the present invention is 10 μm-100 μm detected by scanning electron microscope. The base layer of the biological patch of the present invention has both porous and groove texture structures, which can not only regulate the oriented growth and distribution of cells, but also the mechanical properties of the groove texture structure can enable the cell matrix layer to better adhere to the base layer on, to avoid falling off. The product of the present invention has a stable structure, suitable pore size, porosity and permeability, can simulate normal tissue structure, can provide tissue growth channels and cell matrix, and can carry cells that are beneficial to tissue repair and regeneration. The materials used in the products are natural degradable materials, which have good biocompatibility with the human body. The products produced do not contain foaming agents and crosslinking agents with exogenous toxicity and side effects brought in by the preparation process. The invention has good tensile strength and has a cell matrix layer, which is more conducive to transporting the nutrients required for the cell growth process and providing a good growth environment for the cells. It works well. The method of the invention is simple and easy to implement.
附图说明Description of drawings
图1为本发明所述生物补片基底层表面沟槽纹路示意图。Fig. 1 is a schematic diagram of the groove texture on the surface of the base layer of the biological patch according to the present invention.
图2为细胞在本发明所述生物补片表面图形化的基底层上取向性生长示意图。Fig. 2 is a schematic diagram of the oriented growth of cells on the patterned base layer on the surface of the biological patch according to the present invention.
图3为本发明所述生物补片结构示意图(A为凸形沟槽的生物补片示意图,B为凹形沟槽的生物补片示意图,1为基底层,2为沟槽,3为细胞基质层)。Fig. 3 is the schematic diagram of the biological patch structure of the present invention (A is a schematic diagram of a biological patch with a convex groove, B is a schematic diagram of a biological patch with a concave groove, 1 is a base layer, 2 is a groove, and 3 is a cell basal layer).
具体实施方式Detailed ways
下面结合实施例对本发明作进一步说明。The present invention will be further described below in conjunction with embodiment.
在本发明中所使用的术语,除非另有说明,一般具有本领域普通技术人员通常理解的含义。The terms used in the present invention, unless otherwise specified, generally have the meanings commonly understood by those skilled in the art.
下面结合具体实施例并参照数据进一步详细描述本发明。应理解,这些实施例只是为了举例说明本发明,而非以任何方式限制本发明的范围。The present invention will be further described in detail below in conjunction with specific examples and with reference to data. It should be understood that these examples are only for illustration of the present invention, but not to limit the scope of the present invention in any way.
在以下实施例中,未详细描述的各种过程和方法是本领域中公知的常规方法。In the following examples, various procedures and methods not described in detail are conventional methods well known in the art.
实施例1Example 1
(1)施万细胞的培养及纯化(1) Culture and purification of Schwann cells
取新生一天SD大鼠,处死后酒精消毒,取双侧坐骨神经,置于冰浴操作台去除神经外膜及黏连组织,胶原酶/胰酶混合消化完全后离心弃上清液,完全培养基重悬细胞,接种到PDL事先包被好的培养皿中培养。24小时更换成含有阿糖胞苷(10μM)的完全培养基培养48小时,更换为含有HRG(50ng/ml)和Forsklin(2μM)的完全培养基继续培养,每3天换液,直到细胞融合。待细胞融合后,胰酶消化后离心得到细胞沉淀,用1ml含Thy1.1的完全培养基(1:1000)重悬细胞,冰上孵育2小时;离心弃上清,用DMEM和补体的混合物(3:1)重悬细胞,37℃孵育1小时,离心后完全培养基清洗2次,重新接种于培养皿中,隔天换液,细胞长满后即可以使用。One-day-old SD rats were taken from newborns, killed and disinfected with alcohol, and the bilateral sciatic nerves were taken, placed on an ice-bath operating table to remove the epineurium and adhesion tissue, after the collagenase/trypsin mixed digestion was complete, the supernatant was discarded and the complete medium Resuspend the cells and inoculate them into culture dishes coated with PDL. Replace with complete medium containing cytarabine (10μM) for 24 hours and culture for 48 hours, then replace with complete medium containing HRG (50ng/ml) and Forsklin (2μM) to continue culturing, change the medium every 3 days until the cells are confluent . After the cells are fused, trypsinize and centrifuge to obtain the cell pellet, resuspend the cells with 1ml Thy1.1 complete medium (1:1000), incubate on ice for 2 hours; centrifuge to discard the supernatant, and use a mixture of DMEM and complement (3:1) Resuspend the cells, incubate at 37°C for 1 hour, wash with complete medium twice after centrifugation, reseet in the culture dish, change the medium every other day, and use it after the cells are full.
(2)皮肤来源的成纤维细胞的培养(2) Culture of skin-derived fibroblasts
取新生1天的SD大鼠,处死后酒精消毒,取出背部皮肤置于预冷的解剖液中小心地剔除皮下组织(脂肪和皮下筋膜层、血管等);PBS清洗3次后,用手术刀片切成小块(<1mm×1mm),以I型胶原酶(1mg/ml)完全消化后离心弃上清液,完全培养基重悬细胞,接种到培养皿培养,细胞融合90%后传代培养。成纤维细胞在原代培养过程中会有上皮细胞污染,大多数杂细胞(上皮和内皮细胞)会在几次传代后逐渐死亡。因此,本发明所用细胞为传3代以上细胞。Take SD rats born 1 day old, kill them, and disinfect them with alcohol. Take out the back skin and put it in pre-cooled dissecting solution to carefully remove the subcutaneous tissue (fat, subcutaneous fascia layer, blood vessels, etc.); wash with PBS for 3 times, and use a scalpel blade Cut into small pieces (<1mm×1mm), digest completely with type I collagenase (1mg/ml), centrifuge and discard the supernatant, resuspend the cells in the complete medium, inoculate them into culture dishes, and subculture after the cells are 90% confluent . Fibroblasts will be contaminated with epithelial cells during primary culture, and most of the miscellaneous cells (epithelial and endothelial cells) will gradually die after several passages. Therefore, the cells used in the present invention are cells of more than three generations.
(3)皮肤干细胞的培养及定向沿施万细胞分化(3) Culture and orientation of skin stem cells along Schwann cell differentiation
皮肤干细胞的培养及分化参照文献《Isolation of skin-derived precursors(SKPs)and differentiation and enrichment of their Schwann cell progeny》(Jeffrey A Biernaskie,Ian A McKenzie,Jean G Toma&Freda D Miller,NATUREPROTOCOLS,2006(1):2803-2812),简单描述如下:取新生1天的SD大鼠,处死后酒精消毒,取出背部皮肤置于预冷的解剖液中小心地剔除皮下组织(脂肪和皮下筋膜层、血管等);PBS清洗3次后,用手术刀片切成小块(<1mm×1mm),以0.1%的胰酶或XI型胶原酶(1mg/ml)37℃消化45–60min,完培终止消化离心弃上清液,以增殖培养基(DMEM/F12(3:1)包含0.1%双抗,40μg/ml fungizone,40ng/ml FGF2,20ng/ml EGF,2%B27supplement)进行悬浮培养。悬浮培养的细胞球可以进行传代培养已获得足够数量的皮肤干细胞。The culture and differentiation of skin stem cells refer to the literature "Isolation of skin-derived precursors (SKPs) and differentiation and enrichment of their Schwann cell progeny" (Jeffrey A Biernskie, Ian A McKenzie, Jean G Toma&Freda D Miller, NATURE PROTOCOLS, 2006(1): 2803-2812), and the brief description is as follows: 1-day-old newborn SD rats were sacrificed and alcohol-sterilized, the back skin was taken out and placed in pre-cooled dissecting fluid, and the subcutaneous tissue (fat, subcutaneous fascia layer, blood vessels, etc.) was carefully removed; After washing with PBS for 3 times, cut into small pieces (<1mm×1mm) with a scalpel blade, digest with 0.1% trypsin or type XI collagenase (1mg/ml) at 37°C for 45-60min, terminate the digestion and centrifuge The supernatant was cultured in suspension with proliferation medium (DMEM/F12 (3:1) containing 0.1% double antibody, 40 μg/ml fungizone, 40ng/ml FGF2, 20ng/ml EGF, 2% B27supplement). Suspension-cultured cell spheres can be subcultured to obtain a sufficient number of skin stem cells.
将获得的皮肤干细胞进行分化培养以获得施万细胞,具体步骤如下:将皮肤干细胞以分化培养基I(DMEM/F12(3:1)包含0.1%双抗,40μg/ml fungizone,40ng/ml FGF2,20ng/ml EGF,2%B27supplement,10%FBS)培养3天后再于分化培养基II(DMEM/F12(3:1)包含0.1%双抗,5μm forskolin,50ng/ml heregulin-1β,50μg/ml,2%N2supplement,1%FBS)中培养2-3周后即可获得施万细胞集落。挑取集落后扩增的可得大量皮肤干细胞分化的施万细胞(SKP-SC),免疫组化结果显示呈S100阳性。The obtained skin stem cells were differentiated and cultured to obtain Schwann cells, and the specific steps were as follows: the skin stem cells were cultured in differentiation medium I (DMEM/F12 (3:1) containing 0.1% double antibody, 40 μg/ml fungizone, 40ng/ml FGF2 , 20ng/ml EGF, 2% B27supplement, 10% FBS) for 3 days and then in the differentiation medium II (DMEM/F12 (3:1) containing 0.1% double antibody, 5μm forskolin, 50ng/ml heregulin-1β, 50μg/ ml, 2% N2supplement, 1% FBS) for 2-3 weeks to obtain Schwann cell colonies. A large number of Schwann cells (SKP-SC) differentiated from skin stem cells can be obtained after the colonies are picked and expanded, and the immunohistochemical results show that they are S100 positive.
(4)骨髓间充质干细胞的培养(4) Culture of bone marrow mesenchymal stem cells
脱臼处死成年SD大鼠,75%酒精浸泡5min,无菌条件下取股骨、胫骨,暴露骨髓腔,IMDM基础培养液冲洗骨髓腔,收集骨髓。注射器反复抽吸收获的骨髓,制成单细胞悬液。200目筛网过滤,置水平离心机中离心,1000rpm×5min,弃上清。以4×105/cm2的密度接种于IMDM完全培养液(含有胎牛血清10%),置于37℃培养。24h后全量换液,去除未贴壁细胞,以后每3d半量换液。倒置显微镜下逐日观察细胞形态及生长情况。当细胞铺满皿底达90%融合,传代培养。Adult SD rats were sacrificed by dislocation, soaked in 75% alcohol for 5 minutes, femurs and tibias were removed under aseptic conditions to expose the bone marrow cavity, the bone marrow cavity was washed with IMDM basic culture solution, and the bone marrow was collected. The harvested bone marrow was repeatedly aspirated into a syringe to make a single-cell suspension. Filter through a 200-mesh sieve, centrifuge in a horizontal centrifuge at 1000 rpm for 5 min, and discard the supernatant. Inoculate in complete IMDM medium (containing 10% fetal bovine serum) at a density of 4×10 5 /cm 2 , and culture at 37°C. After 24 hours, the medium was changed in full to remove non-adherent cells, and half of the medium was changed every 3 days thereafter. Cell morphology and growth were observed daily under an inverted microscope. When the cells covered the bottom of the dish and reached 90% confluence, they were subcultured.
实施例2生物补片的制备The preparation of embodiment 2 biological patch
(1)弹性印章的制备(1) Preparation of elastic stamp
本发明所使用的弹性印章为聚二甲基硅氧烷(polydimethylsiloxane,PDMS),其制备方法为将室温下配制好的PDMS液体和交联剂按10:1的比例混合均匀后,浇铸到事先采用掩膜曝光获得的具有横向或纵向的沟槽状微图形化分布的硅片基母模板上,如图1所示。然后将其放入真空干燥箱中抽真空排除气泡,并进行干燥固化,最后进行固化后剥离即得到平面PDMS弹性印章。The elastic stamp used in the present invention is polydimethylsiloxane (polydimethylsiloxane, PDMS), and its preparation method is to mix the PDMS liquid prepared at room temperature and the cross-linking agent in a ratio of 10:1, and then cast it to the On the silicon wafer-based master template with horizontal or vertical groove-like micro-pattern distribution obtained by mask exposure, as shown in FIG. 1 . Then put it into a vacuum drying oven to vacuum out air bubbles, dry and cure, and finally peel off after curing to obtain a planar PDMS elastic stamp.
(2)微图形化壳聚糖基底层的制备(2) Preparation of micropatterned chitosan base layer
首先用乙酸溶解壳聚糖配制一定浓度(1%、2%和5%)的溶液,然后将该溶液滴加在 PDMS上,置于-60℃--90℃,冷冻2-4小时,将冷冻后壳聚糖冰体置于碱性溶液中和固定,用水清洗;对定型的壳聚糖基底层进行冷冻干燥,得到具有多孔结构、表面具有沟槽状分布的多孔壳聚糖基底层;First dissolve chitosan with acetic acid to prepare a solution with a certain concentration (1%, 2% and 5%), then add the solution dropwise on PDMS, place at -60°C-90°C, freeze for 2-4 hours, and After freezing, the chitosan ice body is placed in an alkaline solution and fixed, and washed with water; the shaped chitosan base layer is freeze-dried to obtain a porous chitosan base layer with a porous structure and a groove-like distribution on the surface;
(3)细胞基质层的构建(3) Construction of cell matrix layer
将完全培养基缓慢注入培养容器,再加入2.5×107个细胞及无菌处理过的将壳聚糖基底层,再将完全培养基注满整个容器,控制细胞最终密度为1×105/ml,排尽系统内空气后,开始旋转微重力循环灌注培养;旋转式生物反应器放入37℃CO2培养箱中,前24小时转速为10转/分钟,使细胞与壳聚糖基底层充分接触,贴附;24小时后调整旋转式生物反应器旋转速度,使壳聚糖基底层能悬浮到培养液中;继续培养2天后更换为分化培养基培养,以促进细胞外基质分泌;培养2周后终止培养将表面贴附生长有细胞的壳聚糖基底层取出。显微镜显示细胞在表面图形化的壳聚糖基底层上取向性生长,如图2所示。将生长有细胞的壳聚糖基底层进行脱细胞处理,PBS清洗后去离子无菌水37℃低渗10min;加入细胞抽提液于37℃裂解细胞10-15min;PBS清洗3次后加入Dnase I(4mg/ml)37℃消化30min去除DNA,将其进一步进行冻干,得到本发明所述生物补片,如图3所示,A为凸形沟槽的生物补片示意图,B为凹形沟槽的生物补片示意图,1为基底层,2为沟槽,3为细胞基质层。Slowly inject the complete medium into the culture container, then add 2.5×10 7 cells and the aseptically treated chitosan base layer, then fill the entire container with the complete medium, and control the final cell density to 1×10 5 / ml, after exhausting the air in the system, start rotating microgravity circulation perfusion culture; put the rotary bioreactor in a 37°C CO 2 incubator, and the rotating speed is 10 rpm for the first 24 hours, so that the cells and the chitosan substrate layer Adequate contact and attachment; after 24 hours, adjust the rotation speed of the rotary bioreactor so that the chitosan base layer can be suspended in the culture medium; after continuing to cultivate for 2 days, replace it with a differentiation medium to promote the secretion of extracellular matrix; After 2 weeks, the culture was terminated, and the chitosan base layer with cells attached to the surface was taken out. Microscopy showed that the cells grew oriented on the surface patterned chitosan base layer, as shown in Figure 2. The chitosan base layer with cells was decellularized. After washing with PBS, deionized sterile water was hypotonic at 37°C for 10 minutes; the cell extract was added to lyse the cells at 37°C for 10-15 minutes; after washing with PBS for 3 times, DNase was added I (4mg/ml) 37 DEG C digest 30min to remove DNA, it is further freeze-dried, obtains the biological patch of the present invention, as shown in Figure 3, A is the biological patch schematic diagram of convex groove, and B is concave Schematic diagram of a biopatch with grooves, 1 is the basal layer, 2 is the groove, and 3 is the cell matrix layer.
扫描电镜结果显示壳聚糖基底层表面上均匀分布了支持细胞分泌的细胞外基质成分,已制成含有天然细胞基质层的壳聚糖基底层可在-80℃保存备用,也可进一步冷冻干燥保存。然后经冷冻干燥得到含细胞基质的壳聚糖生物补片,壳聚糖基底层表面以及内部分布有丰富的孔隙,细胞基质层附着在基底层以及孔隙表面。经测定孔隙率89%,平均孔径为87-98μm。Scanning electron microscope results show that the extracellular matrix components secreted by supporting cells are evenly distributed on the surface of the chitosan base layer. The chitosan base layer containing the natural cell matrix layer can be stored at -80°C for future use, and can also be further freeze-dried save. Then freeze-dry to obtain the chitosan biological patch containing the cell matrix, the chitosan base layer surface and inside are distributed with abundant pores, and the cell matrix layer adheres to the base layer and the surface of the pores. The measured porosity is 89%, and the average pore diameter is 87-98 μm.
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510273678.1A CN105769381B (en) | 2015-05-26 | 2015-05-26 | A kind of biological sticking patch for tissue damage reparation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510273678.1A CN105769381B (en) | 2015-05-26 | 2015-05-26 | A kind of biological sticking patch for tissue damage reparation |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105769381A CN105769381A (en) | 2016-07-20 |
CN105769381B true CN105769381B (en) | 2018-04-17 |
Family
ID=56389879
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510273678.1A Active CN105769381B (en) | 2015-05-26 | 2015-05-26 | A kind of biological sticking patch for tissue damage reparation |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105769381B (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108815582A (en) * | 2018-07-11 | 2018-11-16 | 中国科学院上海高等研究院 | A kind of humidity response artificial skin and its preparation method and application |
CN109793927A (en) * | 2019-01-24 | 2019-05-24 | 中国人民解放军军事科学院军事医学研究院 | Preparation method of silk fibroin porous scaffold based on extracellular derived matrix modification |
CN111359018B (en) * | 2020-05-06 | 2023-11-14 | 北京潞康科技有限公司 | Double-layer anti-seepage dura mater repairing sheet and preparation method thereof |
CN113150321A (en) * | 2021-04-09 | 2021-07-23 | 南通大学 | Preparation method of hydrogel with different elastic chitosan/acrylamide micro-nano topological structures |
CN114404102B (en) * | 2021-11-26 | 2025-07-15 | 独步吾奇生物医疗科技(江苏)有限公司 | A repair patch and its application |
CN116159185B (en) * | 2022-12-26 | 2024-04-09 | 烟台德胜海洋生物科技有限公司 | Composite acellular matrix material and preparation method thereof |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101253259A (en) * | 2005-07-20 | 2008-08-27 | 苏尔莫迪克斯公司 | Polymer coated nanofibrillar structures and methods for cell maintenance and differentiation |
CN102066558A (en) * | 2008-01-30 | 2011-05-18 | 希斯托金公司 | Extracellular matrix compositions |
CN102316823A (en) * | 2009-02-11 | 2012-01-11 | 新加坡南洋理工大学 | Multi-layered surgical prosthesis |
CN102698318A (en) * | 2012-03-02 | 2012-10-03 | 首都医科大学附属北京朝阳医院 | Biological-material complex patch |
CN202458781U (en) * | 2012-02-14 | 2012-10-03 | 上海交通大学医学院附属上海儿童医学中心 | Lyophilized acellular swine aorta vessel matrix |
CN102793593A (en) * | 2012-09-03 | 2012-11-28 | 于好勇 | Heterogeneous scleral piece used for posterior scleral reinforcement and preparation method thereof |
CN102892880A (en) * | 2010-01-14 | 2013-01-23 | 奥加诺吉尼西斯公司 | Bioengineered tissue constructs and methods for producing and using thereof |
CN103930066A (en) * | 2011-09-12 | 2014-07-16 | 奥加诺沃公司 | Platforms for engineered implantable tissues and organs and methods for their preparation |
CN104414772A (en) * | 2013-09-06 | 2015-03-18 | 山东百多安医疗器械有限公司 | In-vivo degradable and absorbable artificial medical tissue repairing film |
CN104587528A (en) * | 2014-12-26 | 2015-05-06 | 上海交通大学医学院附属仁济医院 | Acellular matrix of human heart valve tissue and preparation and application of acellular matrix |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8298586B2 (en) * | 2009-07-22 | 2012-10-30 | Acell Inc | Variable density tissue graft composition |
WO2013040544A2 (en) * | 2011-09-15 | 2013-03-21 | Cornell University | Biomedical implant for use in fluid shear stress environments |
US10106776B2 (en) * | 2013-05-06 | 2018-10-23 | University Of Houston | Energetic three-dimensional artificial cardiac patch and uses thereof |
-
2015
- 2015-05-26 CN CN201510273678.1A patent/CN105769381B/en active Active
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101253259A (en) * | 2005-07-20 | 2008-08-27 | 苏尔莫迪克斯公司 | Polymer coated nanofibrillar structures and methods for cell maintenance and differentiation |
CN102066558A (en) * | 2008-01-30 | 2011-05-18 | 希斯托金公司 | Extracellular matrix compositions |
CN102316823A (en) * | 2009-02-11 | 2012-01-11 | 新加坡南洋理工大学 | Multi-layered surgical prosthesis |
CN102892880A (en) * | 2010-01-14 | 2013-01-23 | 奥加诺吉尼西斯公司 | Bioengineered tissue constructs and methods for producing and using thereof |
CN103930066A (en) * | 2011-09-12 | 2014-07-16 | 奥加诺沃公司 | Platforms for engineered implantable tissues and organs and methods for their preparation |
CN202458781U (en) * | 2012-02-14 | 2012-10-03 | 上海交通大学医学院附属上海儿童医学中心 | Lyophilized acellular swine aorta vessel matrix |
CN102698318A (en) * | 2012-03-02 | 2012-10-03 | 首都医科大学附属北京朝阳医院 | Biological-material complex patch |
CN102793593A (en) * | 2012-09-03 | 2012-11-28 | 于好勇 | Heterogeneous scleral piece used for posterior scleral reinforcement and preparation method thereof |
CN104414772A (en) * | 2013-09-06 | 2015-03-18 | 山东百多安医疗器械有限公司 | In-vivo degradable and absorbable artificial medical tissue repairing film |
CN104587528A (en) * | 2014-12-26 | 2015-05-06 | 上海交通大学医学院附属仁济医院 | Acellular matrix of human heart valve tissue and preparation and application of acellular matrix |
Also Published As
Publication number | Publication date |
---|---|
CN105769381A (en) | 2016-07-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108525021B (en) | Tissue engineering skin containing blood vessels and hair follicle structures based on 3D printing and preparation method thereof | |
CN105769381B (en) | A kind of biological sticking patch for tissue damage reparation | |
CN103041450B (en) | Cell matrix modified tissue engineering nerve graft for repairing peripheral nerve injury and preparation method thereof | |
JP3543869B2 (en) | Cultured skin and method for producing the same | |
US6916655B2 (en) | Cultured skin and method of manufacturing the same | |
CN104436305B (en) | Cardiac muscle tonifying tablet taking acellular biological membrane as carrier as well as preparation method and application of cardiac muscle tonifying tablet | |
CN103705984B (en) | Collagen scaffold combined with mesenchymal stem cells preparation method and application | |
WO2016168950A9 (en) | Method for in vitro constructing salivary gland organoids and acinus-like | |
Murakami et al. | Fabrication of transplantable human oral mucosal epithelial cell sheets using temperature-responsive culture inserts without feeder layer cells | |
CN106730034B (en) | Artificial nerve graft based on sliced decellularized scaffold and preparation method | |
Zurina et al. | 2D/3D buccal epithelial cell self-assembling as a tool for cell phenotype maintenance and fabrication of multilayered epithelial linings in vitro | |
WO2011094965A1 (en) | Tissue engineering cornea producing method | |
CN104263699A (en) | Culture method for large-scale preparation of clinical treatment level dermal multipotent stem cells for cell transplantation | |
CN105963785A (en) | Acellular matrix material based on adipose-derived stem cell sheet and preparation method of acellular matrix material | |
CN105820998A (en) | Isolation extraction and culture method for human adipose-derived stem cells (ADSCs) for clinical back-transfusion grade cell therapy | |
Murakami et al. | The effect of micropores in the surface of temperature-responsive culture inserts on the fabrication of transplantable canine oral mucosal epithelial cell sheets | |
CN113846050A (en) | A kind of preparation method of tissue organoid | |
CN107254431B (en) | Novel tissue engineering skin preparation method | |
WO2021012677A1 (en) | Bionic pre-vascular material and preparation method and use therefor | |
JP3554412B2 (en) | Substrate for cultured skin, cultured skin and method for producing the same | |
CN106620855A (en) | A method for constructing composite tissue-engineered skin | |
CN104971382B (en) | The mounted artificial active mass of wound and its construction method that a kind of use serum-free and ox pituitary extract nutrient solution are built | |
CN105713869A (en) | In-vitro three-dimensional isolated culture and storage method for hCDMSC (human chorion-derived mesenchymal stem cell) for clinical adoptive therapy | |
CN204971702U (en) | Be used for prosthetic biological patch of tissue lesion | |
CN105238740A (en) | In-vitro screening and culturing method for tissue engineering skin seed epidermal keratinocyte high-simulation in-vivo cell extracellular matrix attachment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |